4//SEC Filing
Quirk Gerald E 4
Accession 0001209191-21-012338
CIK 0001556263other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:15 PM ET
Size
5.6 KB
Accession
0001209191-21-012338
Insider Transaction Report
Form 4
Quirk Gerald E
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2021-02-17+94,000→ 94,000 totalExercise: $11.41Exp: 2031-02-16→ Common Stock (94,000 underlying)
Footnotes (1)
- [F1]This option becomes exercisable as to one quarter (1/4th) of the shares on February 28, 2022, with the remainder vesting in monthly installments equal to one forty-eighth (1/48th) of the original number of shares at the end of each of the next thirty-six (36) months thereafter.
Documents
Issuer
Syros Pharmaceuticals, Inc.
CIK 0001556263
Entity typeother
Related Parties
1- filerCIK 0001479603
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:15 PM ET
- Size
- 5.6 KB